![David McAvoy](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
David McAvoy
Algemeen Adviseur bij TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Vermogen: 14 570 $ op 31-05-2024
Actieve functies van David McAvoy
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Algemeen Adviseur | 01-03-2024 | - |
Villages of Indiana | Directeur/Bestuurslid | - | - |
Loopbaan van David McAvoy
Eerdere bekende functies van David McAvoy
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
FRESH TRACKS THERAPEUTICS, INC. | Compliance Officer | 01-01-2019 | 01-09-2023 |
Algemeen Adviseur | 01-01-2019 | 01-09-2023 | |
ELI LILLY AND COMPANY | Corporate Officer/Principal | - | - |
Vical, Inc.
![]() Vical, Inc. Pharmaceuticals: MajorHealth Technology Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA. | Compliance Officer | 31-08-2019 | - |
Algemeen Adviseur | 31-08-2019 | - | |
Brickell Subsidiary, Inc.
![]() Brickell Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology Brickell Subsidiary, Inc. operates as a clinical-stage pharmaceutical company. It focuses on the development of differentiated, innovative drug therapies for the treatment of skin diseases. The firm specializes in Hyperhidrosis, Cutaneous T-Cell Lymphoma and Psoriasis areas. The company was founded by Reginald L. Hardy and Andrew D. Sklawer in November 2009 and is headquartered in Boulder, CO. | Compliance Officer | 01-01-2019 | - |
Algemeen Adviseur | 01-01-2019 | - | |
ENDOCYTE, INC. | Compliance Officer | 01-01-2018 | - |
Algemeen Adviseur | 01-01-2018 | - |
Opleiding van David McAvoy
Indiana University | Graduate Degree |
University of Notre Dame | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 9 |
Israël | 2 |
Operationeel
General Counsel | 5 |
Compliance Officer | 4 |
Graduate Degree | 1 |
Sectoraal
Health Technology | 7 |
Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 3 |
---|---|
FRESH TRACKS THERAPEUTICS, INC. | Health Technology |
ELI LILLY AND COMPANY | Health Technology |
TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Health Technology |
Bedrijven in privébezit | 4 |
---|---|
Endocyte, Inc.
![]() Endocyte, Inc. Pharmaceuticals: MajorHealth Technology Endocyte, Inc. engages in the development of targeted therapies for the treatment of cancer and inflammatory diseases. It uses a proprietary technology to create novel small molecule drug conjugates and companion imaging diagnostics for personalized targeted therapies. Its small molecule drug conjugates are actively target receptors that are over-expressed on diseased cells. The company was founded by P. Ron Ellis and Philip S. Low on December 6, 1995 and is headquartered in West Lafayette, IN. | Health Technology |
Villages of Indiana | |
Vical, Inc.
![]() Vical, Inc. Pharmaceuticals: MajorHealth Technology Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA. | Health Technology |
Brickell Subsidiary, Inc.
![]() Brickell Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology Brickell Subsidiary, Inc. operates as a clinical-stage pharmaceutical company. It focuses on the development of differentiated, innovative drug therapies for the treatment of skin diseases. The firm specializes in Hyperhidrosis, Cutaneous T-Cell Lymphoma and Psoriasis areas. The company was founded by Reginald L. Hardy and Andrew D. Sklawer in November 2009 and is headquartered in Boulder, CO. | Health Technology |
- Beurs
- Insiders
- David McAvoy
- Ervaring